AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ABACAVIR SULFATE

12 registrations across 5 African markets— 9 active

Markets with ABACAVIR SULFATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
ABLADO PAED🇿🇦South AfricaCipla Medpro (Pty) LtdactiveMay 2029
DAMICAVA PAED🇿🇦South AfricaCipla Medpro (Pty) LtdactiveMay 2029
Abacavir Tablets_
Tablet
🇳🇬NigeriaHetero Labs Nigeria LimitedactiveNov 2025
ABACAVIR 20MG/ML ORAL SOLUTION
ORAL SOLUTION
🇲🇼MalawiexpiredMar 2025
ABACAVIR 300MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
ABAC 300MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2013
ABACAVIR SULFATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMYLAN LABORATORIES LIMITED (OTL)active
ABACAVIR SULFATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMYLAN LABORATORIES LIMITED (OTL)active
Abacavir Sulfate Oral Solution USP 20mg/ml
Solution
🇹🇿TanzaniaHetero Labs Limitedactive
Abacavir Sulphate
Tablets
🇹🇿TanzaniaMylan Laboratories Limitedactive
ABACAVIR SULFATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMYLAN LABORATORIES LIMITED (OTL)active
ABACAVIR SULFATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMYLAN LABORATORIES LIMITED (OTL)active

ABACAVIR SULFATE in Africa — Regulatory Overview

ABACAVIR SULFATE is registered across 5 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Tanzania, South Africa and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 9 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.